Company Overview

Update
Founded:
2000
Headquarters:
Cranbury, NJ
Funding:
$19.2M
Categories:
Biotechnology
Description:
Cornerstone is a privately held pharmaceutical company focused on the discovery and development of innovative cancer therapies.

Detailed Description

Update

Cornerstone is a privately held pharmaceutical company uniquely focused on the discovery and development of innovative cancer therapies that exploit the metabolic pathways that are common to different cancer types but different from normal cells and tissues.

They believe that their approach, i.e. understanding and addressing what is similar to cancer types rather than the differences of each, offers the best opportunity to have a profound impact on the clinical treatment of a variety of cancers.

Current Team (10)

Update

Funding Rounds (4) - $19.2M

Update

Board Members and Advisors (3)

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    1 Duncan Drive

    Cranbury, NJ 08512

    USA

Images (1)

Update
  • F0f8255aeb24ef4d8a2f4c1a99f631cd